Takeda and Lundbeck's antidepressant hit with US filing delay
09 June 2009
Katie McQue, Ian Haydock
Takeda and
Lundbeck will postpone the US submission of their antidepressant Lu AA21004 by 18-24 months in order to conduct extra studies, after it failed to meet the endpoints in the current Phase III programme in major depressive disorder.
In the recently completed double-blind randomised Phase...
Please Login to read the full article.
09 June 2009
Katie McQue, Ian Haydock
In the recently completed double-blind randomised Phase...
Please Login to read the full article.
RELATED CONTENT
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
